National Research Corporation
$18.18
▼
-1.04%
2026-04-21 08:28:00
www.nrchealth.com
NMS: NRC
Explore National Research Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$413.53 M
Current Price
$18.18
52W High / Low
$22.79 / $9.76
Stock P/E
35.65
Book Value
$0.62
Dividend Yield
3.52%
ROCE
22.99%
ROE
51.24%
Face Value
—
EPS
$0.5
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
357
Beta
0.41
Debt / Equity
573.55
Current Ratio
0.55
Quick Ratio
0.55
Forward P/E
14.21
Price / Sales
2.73
Enterprise Value
$450.96 M
EV / EBITDA
12.19
EV / Revenue
3.28
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Strong operating margin profile.
- Meaningful dividend yield is available.
Cons
- Leverage is relatively high.
- Current ratio suggests tighter short-term liquidity.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | OneMedNet Corporation | $0.94 | — | $46.93 M | — | 361.52% | 29.62% | $4.22 / $0.3 | $-0.06 |
| 2. | HealthStream, Inc. | $21.34 | 34.36 | $630.28 M | 0.6% | 5.11% | 5.14% | $34.13 / $19.5 | $11.97 |
| 3. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 4. | Spok Holdings, Inc. | $11.48 | 14.99 | $237.98 M | 10.89% | 12.85% | 10.55% | $19.31 / $10.81 | $7.1 |
| 5. | Health Catalyst, Inc. | $1.26 | — | $92.72 M | — | -10.35% | -58.26% | $5.06 / $0.96 | $3.41 |
| 6. | Weave Communications, Inc. | $5.47 | — | $430.21 M | — | -24.81% | -37.56% | $11.32 / $4.24 | $1.05 |
| 7. | Mobile-health Network Solutions | $0.85 | — | $3.54 M | — | — | -47.59% | $8.5 / $0.76 | $2.39 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 35.19 M | 34.61 M | 34.04 M | 33.55 M | 36.91 M |
| Operating Profit | 4.67 M | 7.74 M | 1.59 M | 8.6 M | 9.59 M |
| Net Profit | 1.8 M | 4.12 M | -0.11 M | 5.79 M | 6.56 M |
| EPS in Rs | 0.08 | 0.18 | -0 | 0.25 | 0.29 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 137.39 M | 143.06 M | 148.58 M | 151.57 M |
| Operating Profit | 22.59 M | 35.19 M | 40.05 M | 46.54 M |
| Net Profit | 11.6 M | 24.78 M | 30.97 M | 31.8 M |
| EPS in Rs | 0.51 | 1.09 | 1.36 | 1.4 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 134.88 M | 132.54 M | 122.44 M | 130.46 M |
| Total Liabilities | 120.89 M | 101.25 M | 73.48 M | 58.43 M |
| Equity | 13.99 M | 31.28 M | 48.95 M | 72.03 M |
| Current Assets | 20.21 M | 19.6 M | 24.36 M | 43.72 M |
| Current Liabilities | 36.62 M | 35.86 M | 36.2 M | 33.42 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 26.45 M | 34.62 M | 38.11 M | 36.27 M |
| Investing CF | -10.71 M | -20.28 M | -15.78 M | -9.84 M |
| Financing CF | -15.84 M | -16.76 M | -40.71 M | -55.58 M |
| Free CF | 15.74 M | 19.18 M | 22.33 M | 26.43 M |
| Capex | -10.71 M | -15.45 M | -15.78 M | -9.84 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -3.72% | -1.97% | — | — |
| Earnings Growth % | -19.98% | -2.61% | — | — |
| Profit Margin % | 17.32% | 20.84% | 20.98% | — |
| Operating Margin % | 24.6% | 26.95% | 30.71% | — |
| Gross Margin % | 60.2% | 62.3% | 62.36% | — |
| EBITDA Margin % | 28.87% | 31.45% | 32.53% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-27 | $0.16 |
| 2025-12-26 | $0.16 |
| 2025-09-26 | $0.12 |
| 2025-06-27 | $0.12 |
| 2025-03-28 | $0.12 |
Stock Splits
No stock split history available.